Literature DB >> 754238

[Modifications in urinary homovanillic acid after ingestion of vitamin B6; functional study in autistic children (author's transl)].

G Lelord, E Callaway, J P Muh, J C Arlot, D Sauvage, B Garreau, J Domenech.   

Abstract

Basing their study on the investigations which led to the dopaminergic theory of the psychoses, the authors studied homovanillic acid (principal derivative from dopamine) levels in the urines of 37 autistic children, and 11 normal children acting as controls. The favourable action of vitamin B6 on autism, reported by anglosaxon authors, was confirmed in 15 of the children. Furthermore, vitamin B6 reduces homovanillic acid levels in 33 autistic chilren and increases them in all the control group children.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 754238

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  10 in total

1.  Brief report: an open middle-term study of combined vitamin B6-magnesium in a subgroup of autistic children selected on their sensitivity to this treatment.

Authors:  J Martineau; C Barthelemy; C Cheliakine; G Lelord
Journal:  J Autism Dev Disord       Date:  1988-09

Review 2.  Efficacy of vitamin B6 and magnesium in the treatment of autism: a methodology review and summary of outcomes.

Authors:  S I Pfeiffer; J Norton; L Nelson; S Shott
Journal:  J Autism Dev Disord       Date:  1995-10

Review 3.  Combined vitamin B6-magnesium treatment in autism spectrum disorder.

Authors:  C Nye; A Brice
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19

4.  Effect of Supplementation on Levels of Homovanillic and Vanillylmandelic Acids in Children with Autism Spectrum Disorders.

Authors:  Paulina Gątarek; Joanna Kałużna-Czaplińska
Journal:  Metabolites       Date:  2022-05-09

5.  Amisulpride versus bromocriptine in infantile autism: a controlled crossover comparative study of two drugs with opposite effects on dopaminergic function.

Authors:  S Dollfus; M Petit; J F Menard; P Lesieur
Journal:  J Autism Dev Disord       Date:  1992-03

6.  Catecholamines metabolism in infantile autism: a controlled study of 22 autistic children.

Authors:  J M Launay; C Bursztejn; P Ferrari; C Dreux; A Braconnier; E Zarifian; S Lancrenon; J Fermanian
Journal:  J Autism Dev Disord       Date:  1987-09

7.  Effects of pyridoxine and magnesium on autistic symptoms--initial observations.

Authors:  G Lelord; J P Muh; C Barthelemy; J Martineau; B Garreau; E Callaway
Journal:  J Autism Dev Disord       Date:  1981-06

8.  Urinary free and conjugated catecholamines and metabolites in autistic children.

Authors:  C Barthelemy; N Bruneau; J M Cottet-Eymard; J Domenech-Jouve; B Garreau; G Lelord; J P Muh; L Peyrin
Journal:  J Autism Dev Disord       Date:  1988-12

9.  Dopamine-beta-hydroxylase (DBH) and homovanillic acid (HVA) in autistic children.

Authors:  C Garnier; E Comoy; C Barthelemy; I Leddet; B Garreau; J P Muh; G Lelord
Journal:  J Autism Dev Disord       Date:  1986-03

10.  Urinary metabolomics using gas chromatography-mass spectrometry: potential biomarkers for autism spectrum disorder.

Authors:  Zaib Un Nisa Khan; Prem Chand; Hafsa Majid; Sibtain Ahmed; Aysha Habib Khan; Azeema Jamil; Saba Ejaz; Ambreen Wasim; Khaleel Ahmad Khan; Lena Jafri
Journal:  BMC Neurol       Date:  2022-03-17       Impact factor: 2.474

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.